KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Cash from Operations: 2010-2015

Historic Cash from Operations for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2015 value amounting to -$14.8 million.

  • Biocryst Pharmaceuticals' Cash from Operations fell 6.75% to -$14.8 million in Q4 2015 from the same period last year, while for Dec 2015 it was -$13.1 million, marking a year-over-year increase of 65.98%. This contributed to the annual value of -$52.0 million for FY2024, which is 45.32% up from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Cash from Operations of -$14.8 million as of Q4 2015, which was down 17.12% from -$12.7 million recorded in Q3 2015.
  • Over the past 5 years, Biocryst Pharmaceuticals' Cash from Operations peaked at $18.1 million during Q2 2015, and registered a low of -$14.8 million during Q4 2015.
  • Moreover, its 3-year median value for Cash from Operations was -$8.3 million (2013), whereas its average is -$6.5 million.
  • In the last 5 years, Biocryst Pharmaceuticals' Cash from Operations tumbled by 207.64% in 2014 and then surged by 354.83% in 2015.
  • Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' Cash from Operations stood at -$4.0 million in 2011, then tumbled by 76.46% to -$7.0 million in 2012, then soared by 35.78% to -$4.5 million in 2013, then tumbled by 207.64% to -$13.9 million in 2014, then declined by 6.75% to -$14.8 million in 2015.
  • Its Cash from Operations stands at -$14.8 million for Q4 2015, versus -$12.7 million for Q3 2015 and $18.1 million for Q2 2015.